News

Gabriella Ngang, of Farmington Hills, is one of three in Michigan to take part in a clinical trial of a new sickle cell ...
Sickle cell disease is one of the most common genetic blood disorders in the world. It affects millions globally, with the ...
Over a hundred sickle cell warriors and their families turned out in support for World Sickle Cell Day at West Oakland’s ...
Beam Therapeutics Inc. (NASDAQ:BEAM) ranks among the best CRISPR stocks to buy. On June 13, Beam Therapeutics Inc.
Sickle Cell Disease Market Insight, Epidemiology And Market Forecast - 2034The sickle cell disease treatment market is experiencing signific ...
Sickle cell disease affects about 100,000 people in the U.S., and 90% of patients are Black, according to NIH.
Families of those who have sickle cell disease in the Philadelphia area are pushing for more research and a cure.
A researcher at Duke University, speaks out after her NIH grant for sickle cell research was terminated. The $750,000 funding ...
Some doctors told him he'd live with the disease forever, but Khaled Alsheebani never stopped believing treatments would ...
Gene therapy for sickle cell disease may help improve a major contributing factor to stroke risk in patients, reports a new ...
It’s a disease that not many know about, despite estimates indicating that India carries the second-highest burden globally. Sickle cell disease, a group of inherited blood disorders, affects ...